PATENT CLAIM ANALYSIS

Application Number: 15895855
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["514", "630000"]

Abstract:
Compounds that are PSMA ligands, pharmaceutical compositions comprising these compounds, methods for treating and detecting cancers in a subject, methods for identifying cancer cells in a sample are described herein.

Claim (Index 26):
A method of treating cancer in a subject in need thereof, the method comprising:\n administering to the subject a therapeutically effective amount of a compound having the following formula (I): wherein: n and n 1  are each independently 1, 2, 3, or 4; L comprises at least one ring selected from the group consisting of an optionally substituted 4 to 7 membered nonaromatic heterocyclic ring and an optionally substituted C4-C7 cycloalkyl ring; B comprises at least one glutamic acid residue; and Y is a H of B or includes at least one of a detectable moiety, therapeutic agent, or a theranostic agent that is directly or indirectly linked to B.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14767984', '15629281', '15691407', '15623353', '12744982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812724963850118
- 35 USC 102 Novelty (BERT): 0.6262254572019742
- Combined Prediction Score: 0.7657677924667081
- Mean Citation Score: 351.42230600000005
- Max Citation Score: 603.68317
- Similarity Product: 528.4420500135934

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test